ATE548371T1 - Tricyclische verbindung und deren medizinische verwendung - Google Patents

Tricyclische verbindung und deren medizinische verwendung

Info

Publication number
ATE548371T1
ATE548371T1 AT07850267T AT07850267T ATE548371T1 AT E548371 T1 ATE548371 T1 AT E548371T1 AT 07850267 T AT07850267 T AT 07850267T AT 07850267 T AT07850267 T AT 07850267T AT E548371 T1 ATE548371 T1 AT E548371T1
Authority
AT
Austria
Prior art keywords
substituent
optionally
ring
hydrocarbon group
group optionally
Prior art date
Application number
AT07850267T
Other languages
English (en)
Inventor
Osamu Uchikawa
Tatsuki Koike
Takafumi Takai
Yasutaka Hoashi
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of ATE548371T1 publication Critical patent/ATE548371T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4355—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT07850267T 2006-12-08 2007-12-07 Tricyclische verbindung und deren medizinische verwendung ATE548371T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006332647 2006-12-08
PCT/JP2007/073680 WO2008069311A1 (ja) 2006-12-08 2007-12-07 三環性化合物およびその医薬用途

Publications (1)

Publication Number Publication Date
ATE548371T1 true ATE548371T1 (de) 2012-03-15

Family

ID=39492186

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07850267T ATE548371T1 (de) 2006-12-08 2007-12-07 Tricyclische verbindung und deren medizinische verwendung

Country Status (12)

Country Link
US (1) US8273761B2 (de)
EP (1) EP2100895B1 (de)
JP (1) JP5227806B2 (de)
KR (1) KR20090086641A (de)
CN (1) CN101605795A (de)
AT (1) ATE548371T1 (de)
AU (1) AU2007329879A1 (de)
BR (1) BRPI0719869A2 (de)
CA (1) CA2671354A1 (de)
EA (1) EA200970555A1 (de)
MX (1) MX2009006078A (de)
WO (1) WO2008069311A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8247429B2 (en) 2006-12-28 2012-08-21 Takeda Pharmaceutical Company Limited Tricyclic compound and pharmaceutical use thereof
AR091699A1 (es) * 2012-07-10 2015-02-25 Astellas Pharma Inc Derivado de indol carboxamida
EP2884275A4 (de) * 2012-07-10 2016-04-13 Astellas Pharma Inc Pharmazeutische zusammensetzung zur behandlung oder prävention von stressbedingter harninkontinenz oder mischinkontinenz sowie verfahren zum screening von verbindungen zum einbringen in diese pharmazeutische zusammensetzung
CA2989140A1 (en) * 2015-06-12 2016-12-15 Mayo Foundation For Medical Education And Research Mumps virus as a potential oncolytic agent
CA3010804A1 (en) 2016-01-08 2017-07-13 Takeda Pharmaceutical Company Limited Prophylactic or therapeutic agent for autism spectrum disorder
KR20180100627A (ko) 2016-01-08 2018-09-11 다케다 야쿠힌 고교 가부시키가이샤 섬망의 예방 또는 치료제
AU2019231551B2 (en) 2018-03-09 2023-08-03 Recurium Ip Holdings, Llc Substituted 1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-ones

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9326192D0 (en) 1993-12-22 1994-02-23 Glaxo Group Ltd Chemical compounds
US5998461A (en) 1994-10-21 1999-12-07 Adir Et Compagnie Tricyclic amide compounds
FR2725985B1 (fr) 1994-10-21 1996-11-15 Adir Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2732969B1 (fr) * 1995-04-14 1997-05-16 Adir Nouveaux composes pyridiniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6034239A (en) 1996-03-08 2000-03-07 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
DK0885210T5 (da) 1996-03-08 2008-10-13 Takeda Pharmaceutical Tricykliske forbindelser med bindingsaffinitet for melatoninreceptorer, deres fremstilling og anvendelse
JP2006528685A (ja) 2003-05-06 2006-12-21 スミスクライン ビーチャム コーポレーション 新規化合物
WO2006027424A1 (fr) * 2004-08-12 2006-03-16 Inria Institut National De Recherche En Informatique Et En Automatique Dispositif de contrôle de communications
FR2874611B1 (fr) 2004-08-31 2006-11-17 Servier Lab Nouveaux derives d'imidazopyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE502005002224D1 (de) 2005-05-13 2008-01-24 Sefar Ag Leiterplatte und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
JP5227806B2 (ja) 2013-07-03
CA2671354A1 (en) 2008-06-12
KR20090086641A (ko) 2009-08-13
AU2007329879A1 (en) 2008-06-12
BRPI0719869A2 (pt) 2014-04-15
US20100029707A1 (en) 2010-02-04
EP2100895A4 (de) 2009-12-23
WO2008069311A1 (ja) 2008-06-12
CN101605795A (zh) 2009-12-16
EP2100895A1 (de) 2009-09-16
MX2009006078A (es) 2009-09-18
EP2100895B1 (de) 2012-03-07
US8273761B2 (en) 2012-09-25
EA200970555A1 (ru) 2010-02-26
JPWO2008069311A1 (ja) 2010-03-25

Similar Documents

Publication Publication Date Title
ATE548371T1 (de) Tricyclische verbindung und deren medizinische verwendung
PL1891029T3 (pl) Związki organiczne do leczenia stanów zapalnych lub alergicznych
TW200833675A (en) Nicotinamide derivatives
DK1853602T3 (da) Kemiske forbindelser
DK1853588T3 (da) Kemiske forbindelser
DK1740584T3 (da) Kondenseret chinolinderivat og anvendelse deraf
CY1110952T1 (el) Παραγωγα κινουκλιδινης και η χρηση αυτων ως μουσκαρινικοι ανταγωνιστες υποδοχεων μ3
EA201000050A1 (ru) Замещенные бициклолактамные соединения
EA200870117A1 (ru) Азаиндоловые ингибиторы аурора-киназ
TW200726753A (en) 2,4-diamino-pyrimidines as aurora inhibitors
GEP20115241B (en) Indole compound
TW200716606A (en) Chemical compounds
TW200800963A (en) Chemical compounds
TW200740752A (en) 4-Biarylyl-1-phenylazetidin-2-ones
BRPI0608436A2 (pt) derivados de n-(n-sulfonilaminometil) ciclopropanocarboxamida utilizáveis para o tratamento de dor
ATE524432T1 (de) Aminverbindung und deren verwendung für medizinische zwecke
IL209649A0 (en) Substituted heterocycle derivatives
ATE449776T1 (de) Pyrroloä2,3-cüpyridinderivate
CY1113171T1 (el) Αντιφλεγμονωδεις παραγοντες
EA200970642A1 (ru) Трициклическое соединение и его фармацевтическое применение
ATE488510T1 (de) Heterocyclische derivate, deren herstellung und therapeutische verwendung
ATE532791T1 (de) In der 8-stellung modifiziertes purin- nukleosidderivat und dessen medizinische verwendung
MX2009005242A (es) Derivados de 3-(hetero)arilisoquinolinamida sustituida en posición 5, 6 o 7 y uso terapeutico del mismo.
EA200971003A1 (ru) Бициклическое соединение и его фармацевтическое применение
NO20080828L (no) Anti-arytmiforloperforbindelser, metoder for syntese og metoder for bruk